Industry Update: Pharmaceuticals
VRC is proud to release its latest industry report. The report provides a concise, insightful update on the Pharmaceutical industry including recent transactions, market multiples, company performance and purchase price allocation percentages.
Industry Highlights
- On December 28, 2021, Novo Nordisk completed the acquisition of Dicerna Pharmaceuticals, Inc. for approximately $3.2 billion. Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercializing of ribonucleic acid interference (RNAi)-based pharmaceuticals.
- On December 16, 2021, Allergan Aesthetics, an AbbVie company, announced the successful completion of its acquisition of Soliton, Inc. for approximately $580 million. The addition of Soliton and its technology complements Allergan Aesthetics’ portfolio of non-invasive body contouring treatments to now include a proven treatment for the appearance of cellulite.
